Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105949040A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel lithiation-boration route offers high purity >99.9% and yield >66% for pharmaceutical intermediates manufacturing with reduced costs.